Authors:
OVERKAMP D
GAUTIER JF
RENN W
PICKERT A
SCHEEN AJ
SCHMULLING RM
EGGSTEIN M
LEFEBVRE PJ
Citation: D. Overkamp et al., GLUCOSE-TURNOVER IN HUMANS IN THE BASAL STATE AND AFTER INTRAVENOUS GLUCOSE - A COMPARISON OF 2 MODELS, American journal of physiology: endocrinology and metabolism, 36(2), 1997, pp. 284-296
Authors:
KNISEL W
PFOHL M
MULLER M
BESENTHAL I
DINICUOLO A
VOELKER W
RISLER T
EGGSTEIN M
Citation: W. Knisel et al., COMPARATIVE LONG-TERM EXPERIENCE WITH IMMUNOADSORPTION AND DEXTRAN SULFATE CELLULOSE ADSORPTION FOR EXTRACORPOREAL ELIMINATION OF LOW-DENSITY LIPOPROTEINS, The Clinical investigator, 72(9), 1994, pp. 660-668
Authors:
LUFT D
PAGALLIES OB
KONZ K
MANN K
RENN W
EGGSTEIN M
Citation: D. Luft et al., DIFFERENTIAL-DIAGNOSIS OF NEUROPATHIC LESIONS IN DIABETIC AND ALCOHOLIC PATIENTS, The Clinical investigator, 72(3), 1994, pp. 200-205
Authors:
LINGENFELSER T
BUETTNER UW
UHL H
RENN W
TOBIS M
TEICHMANN R
EGGSTEIN M
JAKOBER B
Citation: T. Lingenfelser et al., RECOVERY OF HYPOGLYCEMIA-ASSOCIATED COMPROMISED CEREBRAL FUNCTION AFTER A SHORT INTERVAL OF EUGLYCEMIA IN INSULIN-DEPENDENT DIABETIC-PATIENTS, Electroencephalography and clinical neurophysiology, 92(3), 1994, pp. 196-203
Authors:
KNISEL W
DINICUOLO A
PFOHL M
MULLER H
RISLER T
EGGSTEIN M
SEIFRIED E
Citation: W. Knisel et al., DIFFERENT EFFECTS OF 2 METHODS OF LOW-DENSITY-LIPOPROTEIN APHERESIS ON THE COAGULATION AND FIBRINOLYTIC SYSTEMS, Journal of internal medicine, 234(5), 1993, pp. 479-487
Authors:
LINGENFELSER T
PICKERT A
PFOHL M
RENN W
RADJAIPOUR M
COLLET C
EGGSTEIN M
JAKOBER B
Citation: T. Lingenfelser et al., HYPOTHALAMIC-PITUITARY ACTIVATION DOES NOT DIFFER DURING HUMAN AND PORCINE INSULIN-INDUCED HYPOGLYCEMIA IN INSULIN-DEPENDENT DIABETES-MELLITUS, The Clinical investigator, 72(1), 1993, pp. 56-59
Authors:
STUMVOLL M
SCHNAUDER G
OVERKAMP D
BUETTNER UW
GRODD W
EGGSTEIN M
Citation: M. Stumvoll et al., SYSTEMIC VASCULITIS POSITIVE FOR CIRCULATING ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AND WITH PREDOMINANTLY NEUROLOGICAL PRESENTATION, The Clinical investigator, 71(8), 1993, pp. 613-615
Authors:
LINGENFELSER T
BUETTNER UW
SOMMERWERCK U
RENN W
EGGSTEIN M
JAKOBER B
Citation: T. Lingenfelser et al., NEUROPHYSIOLOGICAL IMPAIRMENTS IN IDDM PATIENTS DURING EUGLYCEMIA ANDHYPOGLYCEMIA, Diabetes care, 16(11), 1993, pp. 1438-1445
Authors:
LINGENFELSER T
BUETTNER UW
TOBIS M
RENN W
EGGSTEIN M
JAKOBER B
Citation: T. Lingenfelser et al., EVIDENCE FOR A CENTRAL DIABETIC NEUROPATHY AS ASSESSED FROM NEUROPHYSIOLOGICAL MEASUREMENTS, Diabetologia, 36, 1993, pp. 10000049-10000049
Citation: D. Overkamp et al., GLUCOSE-TURNOVER IN TYPE-II DIABETES EVALUATED BY TRACER BOLUS INJECTION TECHNIQUE, Diabetologia, 36, 1993, pp. 10000147-10000147
Authors:
FRITSCHE A
SCHNAUDER G
EGGSTEIN M
SCHMULLING RM
Citation: A. Fritsche et al., BLOOD-GLUCOSE PERCEPTION (BGP) IN TYPE-1 DIABETIC-PATIENTS DURING EXERCISE AND AFTER CONSUMPTION OF ALCOHOL, Diabetologia, 36, 1993, pp. 10000152-10000152
Authors:
SCHNAUDER G
PFOHL M
BRAUN D
ENDERLE M
BESENTHAL I
RENN W
EGGSTEIN M
JAKOBER B
Citation: G. Schnauder et al., EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY-ACIDS ON POSTPRANDIAL LIPIDHYDRATE AND CARBOHYDRATE-METABOLISM, Diabetologia, 36, 1993, pp. 10000194-10000194
Authors:
LINGENFELSER T
RENN W
EGGSTEIN M
REINAUER M
JAKOBER B
Citation: T. Lingenfelser et al., RESTORATION OF IMPAIRED COUNTERREGULATORY HORMONE RESPONSE, SYMPTOM PERCEPTION AND CEREBRAL FUNCTION BY SHORT-TERM EUGLYCEMIA IN IDDM, Diabetes, 42, 1993, pp. 243-243
Authors:
PICKERT A
LINGENFELSER T
PICKERT C
BIRBAUMER N
OVERKAMP D
EGGSTEIN M
Citation: A. Pickert et al., COMPARISON OF A MECHANIZED VERSION OF THE KONIG REACTION AND A FLUORESCENCE POLARIZATION IMMUNOASSAY FOR THE DETERMINATION OF NICOTINE METABOLITES IN URINE, Clinica chimica acta, 217(2), 1993, pp. 143-152
Authors:
BEHOUNEK BD
MARKOWITZ JS
BERGMAN M
MCGOVERN ME
KASSLERTAUB KB
VANHANEN H
ELORANTA M
JUVONEN J
KANTOLA I
KEKKI S
KIVELA H
KNUTAR F
NISSEN M
SALMI J
SALONEN R
TARPILA S
TUNTURIHIHNALA H
AMANN FW
BERENDES G
BONNER G
DUBACH UC
EGGSTEIN M
FRANKENBERG HV
FROER KL
HOHL H
HOPPE F
KUMMER H
MARZ W
MOCCETTI T
NOSEDA G
REUTTER FW
SCHWENKE R
VOSSCHULTE G
WAMBACH G
WEIDMANN P
BONNIER JJRM
DEWEERD P
HUIGE MC
JANSEN LJ
TERIJDT AJ
TEVELDE K
OLSSON AG
LARSSON H
ASPLUND J
DAHLQVIST A
LONNQVIST F
FRITHZ G
HOGLUND C
KJELLSTROM T
KUYLENSTIERNA J
MOLLER B
OSTERGREN J
CRAMB R
DAVIES J",IVERSON,"JOHNSTON GD
MUNRO A
PEACOCK I
RITCHIE LD
RITTER J
RYLANCE PB
SEVER PS
SIMMONS RL
Citation: Bd. Behounek et al., EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS, The American journal of cardiology, 72(14), 1993, pp. 1031-1037